Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
暂无分享,去创建一个
S. Terry | M. Benson | Yinglu Guo | A. Taille | R. Buttyan | F. Vacherot | D. Bemis | J. Capodice | X. Yang | J. Kitajewski | Y. Guo | M-W Chen | X. Yang
[1] D. Chopin,et al. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells. , 2005, Cancer research.
[2] K. Marumo,et al. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN‐mutated prostate cancer cells , 2005, The Prostate.
[3] R. Nusse,et al. Wnt3a Growth Factor Induces Androgen Receptor-Mediated Transcription and Enhances Cell Growth in Human Prostate Cancer Cells , 2004, Cancer Research.
[4] E. Messing,et al. Androgen deprivation therapy for prostate cancer: Current status and future prospects , 2004, The Prostate.
[5] Lisa L Gomez,et al. Critical Role for Protein Phosphatase 2A Heterotrimers in Mammalian Cell Survival* , 2004, Journal of Biological Chemistry.
[6] Hans Clevers,et al. Signaling pathways in intestinal development and cancer. , 2004, Annual review of cell and developmental biology.
[7] A. Potti,et al. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.
[8] J. Gregg,et al. Molecular alterations associated with LNCaP cell progression to androgen independence , 2004, The Prostate.
[9] Chawnshang Chang,et al. Androgen Receptor Coregulators in Prostate Cancer , 2004, Clinical Cancer Research.
[10] Jeong Hoon Kim,et al. Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. , 2004, The Journal of biological chemistry.
[11] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[12] Pamela A. Silver,et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. , 2003, Cancer cell.
[13] J. Kreisberg,et al. Akt in prostate cancer: possible role in androgen-independence. , 2003, Current drug metabolism.
[14] Desok Kim,et al. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. , 2003, The Journal of urology.
[15] E. Gelmann,et al. β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription , 2003, Molecular and Cellular Biology.
[16] Chawnshang Chang,et al. Phosphorylation‐dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase , 2002, The EMBO journal.
[17] C. Chuong,et al. Synergistic Coactivator Function by Coactivator-associated Arginine Methyltransferase (CARM) 1 and β-Catenin with Two Different Classes of DNA-binding Transcriptional Activators* , 2002, The Journal of Biological Chemistry.
[18] D. Longo,et al. Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.
[19] D. Woods,et al. Phosphorylation of HDM2 by Akt , 2002, Oncogene.
[20] D. Tindall,et al. Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.
[21] Marty W. Mayo,et al. WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.
[22] W. Isaacs,et al. Detection and analysis of β‐catenin mutations in prostate cancer , 2000 .
[23] S. Sokol,et al. A Positive Role for the PP2A Catalytic Subunit in Wnt Signal Transduction* , 2000, Journal of Biological Chemistry.
[24] H Clevers,et al. Catenins, Wnt signaling and cancer. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] Frank McCormick,et al. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.
[26] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[27] C. S. Young,et al. Wnt-1 Induces Growth, Cytosolic β-Catenin, and Tcf/Lef Transcriptional Activation in Rat-1 Fibroblasts , 1998, Molecular and Cellular Biology.
[28] T. Sugimura,et al. APC gene mutations in human prostate cancer. , 1996, Japanese journal of clinical oncology.
[29] A. Saltzman,et al. Androgen receptor: an overview. , 1995, Critical reviews in eukaryotic gene expression.